The Potential of Resveratrol as an Anticancer Agent: Updated Overview of Mechanisms, Applications, and Perspectives

Md Rezaul Islam1, Rahaf Ajaj2, Abdur Rauf3

  • 1Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University, Dhaka, Bangladesh.

Archiv Der Pharmazie
|September 29, 2025
PubMed

Insights

Resveratrol, a natural polyphenol, shows anticancer potential by affecting cell growth and spread. Research highlights its mechanisms and suggests improvements for clinical use, overcoming bioavailability challenges.

Area of Science:

  • Natural product chemistry
  • Molecular oncology
  • Pharmacology

Background:

  • Resveratrol, a polyphenol from plants, exhibits significant health benefits and anticancer properties.
  • It modulates cancer-related signaling pathways via antiproliferative, proapoptotic, anti-inflammatory, and antiangiogenic mechanisms.
  • Resveratrol's role in regulating oxidative stress and epigenetics adds to its therapeutic promise.

Purpose of the Study:

  • To review the anticancer mechanisms of resveratrol, including structural aspects.
  • To analyze its impact on signaling networks in various cancer models.
  • To update knowledge on recent findings (last 5 years) and in vivo data.

Main Methods:

  • Literature review focusing on recent studies (last 5 years) and in vivo data.
  • Analysis of resveratrol's effects on cancer signaling pathways.
  • Exploration of structural contributions to its anticancer activity.

Main Results:

  • Resveratrol demonstrates broad anticancer effects through multiple molecular mechanisms.
  • Its therapeutic potential is supported by preclinical data, but clinical translation faces hurdles.
  • Recent research highlights specific signaling pathways and in vivo efficacy.

Conclusions:

  • Resveratrol possesses significant anticancer potential, acting through diverse mechanisms.
  • Clinical application is limited by bioavailability and dosage issues.
  • Future strategies include novel delivery systems, drug combinations, and derivative development.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K